Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irem Kaymak
Observed names:
I Kaymak,
I. Kaymak,
Kaymak, Irem,
Kaymak, İrem
Institutions:
AstraZeneca (United Kingdom),
University of Würzburg
Observed institutions:
AstraZeneca (United Kingdom),
Van Andel Institute,
University of Würzburg,
Manchester Academic Health Science Centre,
University of Manchester,
Humboldt-Universität zu Berlin,
Charité – Universitätsmedizin Berlin
show all 7
ORCID:
0000-0003-0772-512X
Observed ORCID:
0000-0003-0772-512X
OpenAlex ID:
A5007342135
Immunometabolic Interplay in the Tumor Microenvironment
2020
·
Irem Kaymak
, Kelsey S. Williams
, et al.
·
Cancer Cell
·
355
PDF
Carbon source availability drives nutrient utilization in CD8+ T cells
2022
·
Irem Kaymak
, Katarzyna M. Luda
, et al.
·
Cell Metabolism
·
164
PDF
Ketolysis drives CD8+ T cell effector function through effects on histone acetylation
2023
·
Katarzyna M. Luda
, Joseph Longo
, et al.
·
Immunity
·
152
PDF
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
2017
·
S Ros
, J Flöter
, et al.
·
Oncogene
·
105
Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress
2019
·
Irem Kaymak
, Carina R. Maier
, et al.
·
Cancer Research
·
101
Regulation of Metabolic Activity by p53
2017
·
Jessica Flöter
, Irem Kaymak
, et al.
·
Metabolites
·
90
PDF
T helper 2 cells control monocyte to tissue-resident macrophage differentiation during nematode infection of the pleural cavity
2023
·
Conor M. Finlay
, James E. Parkinson
, et al.
·
Immunity
·
71
PDF
13 C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8 T cells
2024
·
Eric H. Ma
, Michael S. Dahabieh
, et al.
·
Science Advances
·
63
ACLY and ACSS2 link nutrient-dependent chromatin accessibility to CD8 T cell effector responses
2024
·
Irem Kaymak
, McLane J. Watson
, et al.
·
The Journal of Experimental Medicine
·
62
PDF
Immunometabolism in the Tumor Microenvironment
2020
·
Dominic G. Roy
, Irem Kaymak
, et al.
·
Annual Review of Cancer Biology
·
51
Amino acid availability acts as a metabolic rheostat to determine the magnitude of ILC2 responses
2022
·
Suzanne H. Hodge
, Maria Z. Krauss
, et al.
·
The Journal of Experimental Medicine
·
46
PDF
Repression of LKB1 by miR-17∼92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment
2020
·
Said Izreig
, Alexandra Gariepy
, et al.
·
Cell Reports Medicine
·
34
PDF
Protein phosphatase 4 controls circadian clock dynamics by modulating CLOCK/BMAL1 activity
2021
·
Sabrina Klemz
, Thomas Wallach
, et al.
·
Genes & Development
·
16
Single cell RNA-sequencing profiling to improve the translation between human IBD and in vivo models
2023
·
Erik P. Karmele
, Ana Laura Moldoveanu
, et al.
·
Frontiers in Immunology
·
11
PDF
DOP132 An integrated single-cell atlas enables the discovery and validation of a novel candidate therapeutic target for Inflammatory Bowel Disease
2025
·
G De Baets
, J D'Rozario
, et al.
·
Journal of Crohn s and Colitis
·
1
PDF
Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
2026
·
Ros, Susana
, Flöter, Jessica
, et al.
·
ETH Zürich Research Collection
Correction: 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
2026
·
S. Ros
, J. Flöter
, et al.
·
Oncogene
PDF
A ML-framework for the discovery of next-generation IBD targets using a harmonized single-cell atlas of patient tissue
2026
·
Anoushka Joglekar
, Ann Joseph
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Su1962: AN INTEGRATED SINGLE-CELL ATLAS ENABLES THE DISCOVERY AND VALIDATION OF A NOVEL CANDIDATE THERAPEUTIC TARGET FOR INFLAMMATORY BOWEL DISEASE
2025
·
Greet De Baets
, Joshua D’Rozario
, et al.
·
Gastroenterology
DOP40 Inflammatory Bowel Disease single cell atlas construction to enable cell type-specific target identification
2024
·
G De Baets
, J D'Rozario
, et al.
·
Journal of Crohn s and Colitis
PDF
Data from Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress
2023
·
Irem Kaymak
, Carina R. Maier
, et al.
Supplementary Figures 1-7 from Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress
2023
·
Irem Kaymak
, Carina R. Maier
, et al.
PDF
Supplementary Information from Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress
2023
·
Irem Kaymak
, Carina R. Maier
, et al.
PDF
Data from Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress
2023
·
Irem Kaymak
, Carina R. Maier
, et al.
Tokat Başçiftlik halılarının karakteristik özellikleri, gelişim süreci ve coğrafya üzerindeki sosyo-ekonomik etkiler
2023
·
Kaymak, İrem
, Doğan, Elif Sıla
, et al.
·
Bilkent University Institutional Repository (Bilkent University)
Show more works
View as search
Works count:
26
Citation count:
1,322
H-index:
13
I10-index:
14
Year
Topic
Type